Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fox

Showing results (1391-1400 of 1,511) with videos related to

Pageof 152
Sort By:
Brain : a Journal of Neurology|August 14, 2020
Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
JAMA Cardiology|March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical TrialPrem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.
Annals of Clinical and Translational Neurology|March 11, 2021
A population-based study of head injury, cognitive function and pathological markersSarah-Naomi James, Jennifer M Nicholas, Christopher A Lane, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
The Journal of Clinical Investigation|September 14, 2021
Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironmentXinming Su, Yalin Xu, Gregory C Fox, et al.
Circulation|November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM TrialDaniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.
Cancer Research|May 25, 2016
Antagonizing Integrin β3 Increases Immunosuppression in CancerXinming Su, Alison K Esser, Sarah R Amend, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersGaurav V Bhalerao, Pawel J Markiewicz, David L Thomas, et al.
American Journal of Human Genetics|July 15, 2025
A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemiaJeremy B Chang, Connor P Barnhill, Alexander M Apostolov, et al.
American Journal of Human Genetics|February 26, 2013
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK populationJon Beck, Mark Poulter, Davina Hensman, et al.
Pageof 152

Showing results (1391-1400 of 1,511) with videos related to

Sort By:
Pageof 152
Brain : a Journal of Neurology|August 14, 2020
Functional cognitive disorder: dementia's blind spotHarriet A Ball, Laura McWhirter, Clive Ballard, et al.
JAMA Cardiology|March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical TrialPrem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.
Annals of Clinical and Translational Neurology|March 11, 2021
A population-based study of head injury, cognitive function and pathological markersSarah-Naomi James, Jennifer M Nicholas, Christopher A Lane, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
The Journal of Clinical Investigation|September 14, 2021
Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironmentXinming Su, Yalin Xu, Gregory C Fox, et al.
Circulation|November 18, 2024
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM TrialDaniel P Judge, Julian D Gillmore, Kevin M Alexander, et al.
Cancer Research|May 25, 2016
Antagonizing Integrin β3 Increases Immunosuppression in CancerXinming Su, Alison K Esser, Sarah R Amend, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersGaurav V Bhalerao, Pawel J Markiewicz, David L Thomas, et al.
American Journal of Human Genetics|July 15, 2025
A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemiaJeremy B Chang, Connor P Barnhill, Alexander M Apostolov, et al.
American Journal of Human Genetics|February 26, 2013
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK populationJon Beck, Mark Poulter, Davina Hensman, et al.
Pageof 152